MNPR — Monopar Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Monopar Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13.2	16.7	20.3	13.1	7.27
Total Other Current Assets
Total Current Assets	13.2	16.8	20.5	13.2	7.33
Net Property, Plant And Equipment	—	—	—	0.061	0.013
Other Long Term Assets
Total Assets	13.4	16.9	20.5	13.2	7.35
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	0.724	1.18	1.58	3.13	1.76
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.724	1.18	1.58	3.14	1.76
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	12.6	15.7	18.9	10.1	5.59
Total Liabilities & Shareholders' Equity	13.4	16.9	20.5	13.2	7.35
Total Common Shares Outstanding